CXCL12/SDF-1 in IgG4-Related Disease
Conclusion: Modulating B cell development, neoangiogenesis and fibrosis, and SDF-1/CXCL12 may play a role in IgG4-RD. The higher levels observed in IgG4-RD, as compared to SSj, which closely mimics the disease, can be related to a different pattern of lesions, with prevalent fibrosis seen in IgG4-RD. Taken together, these findings suggest that drugs acting on the CXCL12/CXCR4/CXCR7 axis may affect IgG4-RD.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Adenocarcinoma | Autoimmune Disease | Cancer | Cancer & Oncology | Drugs & Pharmacology | Pancreas | Pancreatic Cancer | Pancreatitis | Sjogren's Syndrome | Stem Cell Therapy | Stem Cells | Study